Overexpression of CD155 is associated with PD-1 and PD-L1 expression on immune cells, rather than tumor cells in the breast cancer microenvironment
Sign Up to like & getrecommendations! Published in 2020 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v8.i23.5935
Abstract: BACKGROUND CD155 is an immune checkpoint protein in cancers and interacts with ligands to regulate the immune microenvironment. The expression of CD155 is correlated with the prognosis and pathological features of breast cancer. AIM To… read more here.
Keywords: cd155 expression; cd155; breast cancer; expression ... See more keywords
CD155 expression and its clinical significance in non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2022 at "Oncology Letters"
DOI: 10.3892/ol.2022.13286
Abstract: CD155 serves an important role in tumor progression by promoting cell proliferation and migration. CD155 is also involved in the immune evasion of tumor cells, which may cause the development and progression of tumors. Accordingly,… read more here.
Keywords: cd155 expression; expression; lung; tumor ... See more keywords
CD155 immunohistochemical expression in upper tract urothelial carcinoma predicts poor prognosis.
Sign Up to like & getrecommendations! Published in 2022 at "Oncology letters"
DOI: 10.3892/ol.2022.13534
Abstract: A novel immune checkpoint, CD155/T-cell immunoreceptor with Ig and ITIM domains, has been recognized as a new therapeutic target in addition to conventional immune checkpoints, such as anti-programmed cell death protein 1/programmed cell death ligand… read more here.
Keywords: cd155 expression; immunohistochemical expression; expression; urothelial carcinoma ... See more keywords